Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery, development, manufacturing, and commercialization of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma (MM). The company also has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. It has collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of ciltacabtagene autoleucel. The company was founded in 2014 and is based in Somerset, New Jersey. Legend Biotech Corporation operates as a subsidiary of Genscript Biotech Corporation. more
Time Frame | LEGN | Sector | S&P500 |
---|---|---|---|
1-Week Return | -2.96% | -2.12% | -3% |
1-Month Return | -15.1% | -3.42% | -0.73% |
3-Month Return | -29.78% | -11.13% | 2.87% |
6-Month Return | -16.47% | -5.74% | 7.17% |
1-Year Return | -43.21% | 3.97% | 25.31% |
3-Year Return | -27.46% | 1.05% | 28.38% |
5-Year Return | -7.89% | 34.37% | 81.89% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 57.26M | 75.68M | 89.79M | 117.00M | 285.14M | [{"date":"2019-12-31","value":20.08,"profit":true},{"date":"2020-12-31","value":26.54,"profit":true},{"date":"2021-12-31","value":31.49,"profit":true},{"date":"2022-12-31","value":41.03,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | - | 232.16M | 313.35M | 65.36M | 144.21M | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":74.09,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":20.86,"profit":true},{"date":"2023-12-31","value":46.02,"profit":true}] |
Gross Profit | 57.26M | (156.48M) | (223.55M) | 51.64M | 140.93M | [{"date":"2019-12-31","value":40.63,"profit":true},{"date":"2020-12-31","value":-111.04,"profit":false},{"date":"2021-12-31","value":-158.63,"profit":false},{"date":"2022-12-31","value":36.64,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 100.00% | (206.78%) | (248.97%) | 44.14% | 49.42% | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-206.78,"profit":false},{"date":"2021-12-31","value":-248.97,"profit":false},{"date":"2022-12-31","value":44.14,"profit":true},{"date":"2023-12-31","value":49.42,"profit":true}] |
Operating Expenses | 192.63M | 304.88M | 462.83M | 509.70M | 140.93M | [{"date":"2019-12-31","value":37.79,"profit":true},{"date":"2020-12-31","value":59.82,"profit":true},{"date":"2021-12-31","value":90.8,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":27.65,"profit":true}] |
Operating Income | (130.87M) | (313.35M) | (393.02M) | (455.83M) | (439.49M) | [{"date":"2019-12-31","value":-13087100000,"profit":false},{"date":"2020-12-31","value":-31334600000,"profit":false},{"date":"2021-12-31","value":-39302500000,"profit":false},{"date":"2022-12-31","value":-45582800000,"profit":false},{"date":"2023-12-31","value":-43948500000,"profit":false}] |
Total Non-Operating Income/Expense | 4.86M | (82.62M) | (15.07M) | (692.00K) | (59.39M) | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-1700.27,"profit":false},{"date":"2021-12-31","value":-310.17,"profit":false},{"date":"2022-12-31","value":-14.24,"profit":false},{"date":"2023-12-31","value":-1222.35,"profit":false}] |
Pre-Tax Income | (130.37M) | (307.62M) | (386.21M) | (445.72M) | (520.12M) | [{"date":"2019-12-31","value":-13037000000,"profit":false},{"date":"2020-12-31","value":-30762200000,"profit":false},{"date":"2021-12-31","value":-38620800000,"profit":false},{"date":"2022-12-31","value":-44572400000,"profit":false},{"date":"2023-12-31","value":-52011800000,"profit":false}] |
Income Taxes | 2.60M | (4.14M) | 1.00K | 625.00K | (1.86M) | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-159.3,"profit":false},{"date":"2021-12-31","value":0.04,"profit":true},{"date":"2022-12-31","value":24.02,"profit":true},{"date":"2023-12-31","value":-71.64,"profit":false}] |
Income After Taxes | (132.97M) | (303.48M) | (386.21M) | (446.35M) | (518.25M) | [{"date":"2019-12-31","value":-13297200000,"profit":false},{"date":"2020-12-31","value":-30347700000,"profit":false},{"date":"2021-12-31","value":-38620900000,"profit":false},{"date":"2022-12-31","value":-44634900000,"profit":false},{"date":"2023-12-31","value":-51825400000,"profit":false}] |
Income From Continuous Operations | (132.97M) | (303.48M) | (386.21M) | (446.35M) | (509.31M) | [{"date":"2019-12-31","value":-13297200000,"profit":false},{"date":"2020-12-31","value":-30347700000,"profit":false},{"date":"2021-12-31","value":-38620900000,"profit":false},{"date":"2022-12-31","value":-44634900000,"profit":false},{"date":"2023-12-31","value":-50931200000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (132.97M) | (303.48M) | (386.21M) | (446.35M) | (518.25M) | [{"date":"2019-12-31","value":-13297200000,"profit":false},{"date":"2020-12-31","value":-30347700000,"profit":false},{"date":"2021-12-31","value":-38620900000,"profit":false},{"date":"2022-12-31","value":-44634900000,"profit":false},{"date":"2023-12-31","value":-51825400000,"profit":false}] |
EPS (Diluted) | - | (2.49) | (1.35) | (1.58) | (2.96) | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-249,"profit":false},{"date":"2021-12-31","value":-135,"profit":false},{"date":"2022-12-31","value":-158,"profit":false},{"date":"2023-12-31","value":-296,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
LEGN | |
---|---|
Cash Ratio | 4.48 |
Current Ratio | 4.98 |
Quick Ratio | 4.90 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
LEGN | |
---|---|
ROA (LTM) | -12.28% |
ROE (LTM) | -28.35% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
LEGN | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.36 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.64 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
LEGN | |
---|---|
Trailing PE | NM |
Forward PE | 1000.00 |
P/S (TTM) | 12.00 |
P/B | 5.59 |
Price/FCF | NM |
EV/R | 10.33 |
EV/Ebitda | NM |
Legend Biotech Corp (LEGN) share price today is $34.08
Yes, Indians can buy shares of Legend Biotech Corp (LEGN) on Vested. To buy Legend Biotech Corp from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in LEGN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Legend Biotech Corp (LEGN) via the Vested app. You can start investing in Legend Biotech Corp (LEGN) with a minimum investment of $1.
You can invest in shares of Legend Biotech Corp (LEGN) via Vested in three simple steps:
The 52-week high price of Legend Biotech Corp (LEGN) is $70.13. The 52-week low price of Legend Biotech Corp (LEGN) is $32.5.
The price-to-earnings (P/E) ratio of Legend Biotech Corp (LEGN) is
The price-to-book (P/B) ratio of Legend Biotech Corp (LEGN) is 5.59
The dividend yield of Legend Biotech Corp (LEGN) is 0.00%
The market capitalization of Legend Biotech Corp (LEGN) is $6.23B
The stock symbol (or ticker) of Legend Biotech Corp is LEGN